The U.S. Food and Drug Administration is pleased to announce the launch of its newly redesigned Sentinel Initiative website. The new website was designed to increase organization and usability and assist the Sentinel community with up-to-date information on Sentinel assessments, tools, and news.
Please visit the new website for information on: - Coronavirus (COVID-19) activities, to keep up with how FDA is using Sentinel activities to protect and promote public health during the COVID-19 pandemic
- Completed ARIA assessments & impact, for a list of safety-related outcomes, results, and regulatory impacts
- Drug assessments, where you can search materials based on medical product, safety outcome, and study type
- Publications & presentations, so you can read up on Sentinel activities in journals and conference materials
FDA’s Sentinel Initiative enhances the agency’s ability to proactively monitor the safety and performance of medical products. |
No hay comentarios:
Publicar un comentario